Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
Hospital, physician and other healthcare provider recipients of the CARES Act funding, must be careful to conduct effective diligence and demonstrate compliance with funding...
The intersection of AI and healthcare is transforming clinical practices and patient care. In this podcast, clinicians share their experiences and insights working at...
In part 2 of our podcast series, A&M's Larry Kaiser, M.D., FACS and Marthe Haverkamp, M.D., Ph.D, talk with Kevin Mahoney, CEO, University of...
